BioNTech Plans To Develop A Malaria Vaccine Based On mRNA
The first vaccine in the world for malaria, based on mRNA technology, is planned to be developed by BioNTech – building on its successful development of Covid-19 vaccine. The company plans to begin clinical trials of the malarial vaccine by the end of next year in its effort to completely eradicate the mosquito borne disease…








